Response to: “Drugs for treatment for alcohol use disorders expose to interactions with others … for little benefit if any”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to: “Drugs for treatment for alcohol use disorders expose to interactions with others … for little benefit if any”

Published:2018-08 Issue: Volume:134 Page:220
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Guerzoni Simona,Pellesi Lanfranco^ORCID,Pini Luigi Alberto,Caputo Fabio

Publisher

Elsevier BV

Subject

Pharmacology

Reference6 articles.

1. Drugs for treatment for alcohol use disorders expose to interactions with others … for little benefit if any;Braillon;Pharm. Res.,2018

2. Rates and predictors of relapse after natural and treated remission from alcohol use disorders;Moos;Addiction,2006

3. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder;Reus;Am. J. Psychiatry,2018

4. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate;Palpacuer;Addiction,2018

5. Guideline on the Development of Medicinal Products for the Treatment of Alcohol Dependence;European Medicines Agency,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP